BamSEC and AlphaSense Join Forces
Learn More

Kite Pharma, Inc.

Formerly NASDAQ: KITE
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 3 pages [Name] [Address] [Address] Dear [Name]
12/34/56
EX-10.2
from 10-Q >50 pages Sino-Foreign Co-Operative Joint Venture Contract by and Between Kp Eu C.V. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. Regarding Establishment of Fosun Pharma Kite Biotechnology Co., Ltd
12/34/56
EX-10.1
from 10-Q 3 pages Collaboration and License Agreement
12/34/56
EX-10.5
from 10-K ~5 pages Kite Pharma, Inc. Non-Employee Director Compensation Policy Adopted: June 6, 2014 Amended: December 17, 2015, December 12, 2016 and January 3, 2017
12/34/56
EX-10.4
from 10-K 22 pages Kite Pharma, Inc. (2014 Equity Incentive Plan) Notice of Grant
12/34/56
EX-10.3
from 10-K 25 pages Kite Pharma, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from 10-Q 124 pages Colorado Center Office Lease
12/34/56
EX-10.3
from 10-Q 60 pages Research Collaboration and License Agreement
12/34/56
EX-10.2
from 10-Q 76 pages Research Collaboration and License Agreement by and Between Amgen Inc. and Kite Pharma, Inc. Dated as of December 31, 2014
12/34/56
EX-10.1
from 10-Q 10 pages May 3, 2016 Mr. Paul Jenkinson 33671 Paseo Del Puerto San Juan Capistrano, Ca 92675 Re: Employment Letter 1. Title; Reporting; Duties
12/34/56
EX-10.1
from 8-K 62 pages Air Commercial Real Estate Association Standard Industrial/Commercial Multi-Tenant Lease - Net
12/34/56
EX-10.5
from 10-Q 3 pages National Institutes of Health First Amendment to L-002-2016/0
12/34/56
EX-10.4
from 10-Q 4 pages National Institutes of Health Second Amendment to L-077-2015/0
12/34/56
EX-10.3
from 10-Q 3 pages National Institutes of Health Second Amendment to L-277-2014/0
12/34/56
EX-10.2
from 10-Q 3 pages National Institutes of Health Second Amendment to L-068-2013/0
12/34/56
EX-10.1
from 10-Q 8 pages February 9, 2016 Mr. Timothy Moore 608b Missouri St. San Francisco, Ca 94107 Re: Employment Letter Dear Mr. Moore: Kite Pharma, Inc. (“KITE” or the “Company”) Is Pleased to Offer You the Position of Executive Vice President, Technical Operations, on the Following Terms and Conditions: 1. Title; Reporting; Duties
12/34/56
EX-10.30
from 10-K 35 pages License and Research Agreement
12/34/56
EX-10.29
from 10-K 32 pages The National Institutes of Health Patent License Agreement – Exclusive Cover Page
12/34/56
EX-10.23
from 10-K 6 pages National Institutes of Health First Amendment to L-277-2014/0
12/34/56
EX-10.21
from 10-K 6 pages National Institutes of Health First Amendment to L-068-2013/0
12/34/56